ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.
Men with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC) who are being treated with radium-223 (Xofigo) plus enzalutamide... Read More
Cultural competence, multidisciplinary efforts with diverse faculty, and high-risk screening programs could help to address critical gaps and cancer disparities.... Read More
Advanced practice providers are essential in treating patients with genitourinary cancers, especially as there is a shortage of clinicians in... Read More
Recent trials have determined a survival benefit when chemotherapy is added to frontline treatment for patients with hormone-sensitive metastatic prostate... Read More
